In-Office Clinical Study of the Solo+ TTD

NCT ID: NCT05741333

Last Updated: 2025-04-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

66 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-30

Study Completion Date

2027-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to evaluate the safety and effectiveness of the Solo+ Tympanostomy Tube Device (Solo+ TTD) for the placement of tympanostomy tubes in paediatric patients undergoing a tympanostomy procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study will be a multi-site, prospective, treatment-only study to gather safety and effectiveness data on the use of the Solo+ TTD in-office with topical anesthesia in children aged ≥6 months to \<13 years.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ear Infection Otitis Media

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Solo+ Tympanostomy Tube Device (Solo+ TTD)

The Solo+ TTD is a disposable surgical tool designed to deliver a tympanostomy tube into the tympanic membrane of patients undergoing a tympanostomy tube placement procedure.

Group Type EXPERIMENTAL

Solo+ Tympanostomy Tube Device (Solo+ TTD)

Intervention Type DEVICE

The Solo+ TTD is intended to deliver a tympanostomy tube through the tympanic membrane of a patient.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Solo+ Tympanostomy Tube Device (Solo+ TTD)

The Solo+ TTD is intended to deliver a tympanostomy tube through the tympanic membrane of a patient.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged ≥6 months to \<13 years
* Planned tympanostomy tube insertion
* Patient is able to commit to the follow-up visits and assessments

Exclusion Criteria

* Anatomy that precludes sufficient visualization of the tympanic membrane
* Anatomy that precludes safe access to the tympanic membrane and safe use of the Solo+ TTD
* Narrow ear canals
* Congenital or craniofacial abnormalities affecting the ear
* No baseline audiometry or tympanometry
* Familial history of insensitivity to anesthetic components
* Patient unable to remain still or is unsuitable for protective stabilization to undergo an in-office procedure
Minimum Eligible Age

6 Months

Maximum Eligible Age

13 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AventaMed DAC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Matija Daniel

Role: STUDY_CHAIR

Queen's Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southern Head & Neck Surgery

Alexander City, Alabama, United States

Site Status RECRUITING

North Alabama ENT

Huntsville, Alabama, United States

Site Status RECRUITING

East Alabama ENT

Opelika, Alabama, United States

Site Status RECRUITING

Sacramento ENT

Sacramento, California, United States

Site Status ACTIVE_NOT_RECRUITING

Advanced ENT & Allergy

Louisville, Kentucky, United States

Site Status ACTIVE_NOT_RECRUITING

Specialty Physician Associates

Bethlehem, Pennsylvania, United States

Site Status ACTIVE_NOT_RECRUITING

South Carolina ENT

Columbia, South Carolina, United States

Site Status ACTIVE_NOT_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Keith Jansen

Role: CONTACT

+353 21 492 8980

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Nikki Cordes

Role: primary

Emily Weske

Role: primary

Sierra Macon

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CSP003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Robot Based Tympanic Tube Placement
NCT03569943 WITHDRAWN NA